Janice May Wilson, MD | |
301 University Blvd, University Of Texas Medical Branch-dermatology, Galveston, TX 77555-0783 | |
(409) 772-1911 | |
(409) 772-4456 |
Full Name | Janice May Wilson |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 12 Years |
Location | 301 University Blvd, Galveston, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457612749 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ND0900X | Dermatology - Dermatopathology | Q5126 (Texas) | Secondary |
207R00000X | Internal Medicine | BP10044148 (Texas) | Secondary |
207N00000X | Dermatology | BP20046284 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.
› Verified 2 days ago
Entity Name | Utmb Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.
› Verified 2 days ago
Entity Name | Motaz Albahra Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306879705 PECOS PAC ID: 3678576006 Enrollment ID: O20060824000276 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.
› Verified 2 days ago
Entity Name | Adg Houston Path Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659617009 PECOS PAC ID: 6901283621 Enrollment ID: O20220519000655 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Janice May Wilson, MD 301 University Blvd, Galveston, TX 77555-0783 Ph: (409) 772-1911 | Janice May Wilson, MD 301 University Blvd, University Of Texas Medical Branch-dermatology, Galveston, TX 77555-0783 Ph: (409) 772-1911 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.
...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.
› Verified 2 days ago
Frank Winsett, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1005 Harborside Dr 5th Floor, Galveston, TX 77555 Phone: 409-747-3376 Fax: 409-772-4456 | |
Dr. Ramon Larrea Sanchez, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1501 Broadway St, Galveston, TX 77550 Phone: 409-763-2452 Fax: 409-763-2458 | |
Michael George Wilkerson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Harborside Dr, Galveston, TX 77555 Phone: 409-772-2222 | |
Richard F Wagner Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Harborside Dr, Galveston, TX 77555 Phone: 409-772-2222 | |
Lindy Ross, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1911 | |
Dr. Erica B Kelly, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |